Cap-dependent endonuclease-IN-11, inhibitor of cap-dependent endonuclease (CEN)
Pyruvate Carboxylase-IN-2, inhibitor of pyruvate carboxylase (PC)
Cap-dependent endonuclease-IN-13, inhibitor of cap-dependent endonuclease (CEN)
Molassamide B, serine protease inhibitor
Cap-dependent endonuclease-IN-12, Cap-dependent endonuclease inhibitor
Cap-dependent endonuclease-IN-14, inhibitor of cap-dependent endonuclease (CEN)
Cap-dependent endonuclease-IN-15, inhibitor of cap-dependent endonuclease (CEN)
HDAC-IN-29, pan-HDAC inhibitor
Cap-dependent endonuclease-IN-16, inhibitor of cap-dependent endonuclease (CEN)
Diprovocim-X is a novel and potent small molecule TLR1/TLR2 (toll-like receptor 1/2) agonist with the potential to be used as adjuvant of vaccines. It activates TLRs with EC50 values of 0.14 and 0.75 nM for hTLR1/TLR2 and mTLR1/TLR2, respectively. Diprovocim-X can stimulate both innate and adaptive immune response.